Mani Sharma
CIK 2122411 · SVP, Group Controller · last filed 2026-08-07
Mani Sharma is a SVP, Group Controller who has filed 6 SEC Form 4 insider transactions across 1 company since 2026. The most recent filing shows the insider was granted $327 of AZN on Aug 7, 2026. Across all open-market trades the lifetime net is −$2.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.1M across reported positions. 6 SEC filings were submitted jointly with ASTRAZENECA PLC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.13M
1
6
-$2.21M
Filer Profile
CAMBRIDGE BIOMEDICAL CAMPUS
CAMBRIDGE CB2 0AA
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AZN | SVP, Group Controller | 19,267 | $162.70 | $3.13M | -$2.21M | 6 | 2026-08-07 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-07 | AZN | Grant (A) | +2 | $327 | EDGAR |
| 2026-08-07 | AZN | Grant (A) | +2 | $327 | EDGAR |
| 2026-07-08 | AZN | Grant (A) | +2 | $381 | EDGAR |
| 2026-06-16 | AZN | Grant (A) | +1 | $180 | EDGAR |
| 2026-05-22 | AZN | Sell (S) | −11,893 | -$2.21M | EDGAR |
| 2026-05-08 | AZN | Grant (A) | +2 | $382 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.